Xun Hou

Sorafenib enhances the chemotherapeutic efficacy of S-1 against hepatocellular carcinoma through downregulation of transcription factor E2F-1.

Analysis of the genome-wide DNA methylation profile of side population cells in hepatocellular carcinoma.

Simvastatin enhances the chemotherapeutic efficacy of S-1 against bile duct cancer: E2F-1/TS downregulation might be the mechanism.

DNA methylation profiling identifies EYA4 gene as a prognostic molecular marker in hepatocellular carcinoma.

EYA4 gene functions as a prognostic marker and inhibits the growth of intrahepatic cholangiocarcinoma.

Crosstalk between prognostic long noncoding RNAs and messenger RNAs as transcriptional hallmarks in gastric cancer.

EYA4 inhibits hepatocellular carcinoma growth and invasion by suppressing NF-κB-dependent RAP1 transactivation.

External validation of a modified 8th AJCC TNM system for advanced gastric cancer: Long-term results in southern China.

The PROFILE of assessment program for internal medicine internship of Sun Yat-Sen University.

EYA4 inhibits hepatocellular carcinoma by repressing MYCBP by dephosphorylating β-catenin at Ser552.

Transcriptome hallmarks in infection influence gastric cancer and MALT lymphoma.

CT-based radiomics scores predict response to neoadjuvant chemotherapy and survival in patients with gastric cancer.

Educational needs in the COVID-19 pandemic: a Delphi study among doctors and nurses in Wuhan, China.

KLF5 Is Activated by Gene Amplification in Gastric Cancer and Is Essential for Gastric Cell Proliferation.

Twin grasper-assisted endoscopic mucosa-inverting closure for large perforations after endoscopic full-thickness resection: a new endoscopic technique.